MPM
GMED icon

Meritage Portfolio Management’s Globus Medical GMED Stock Holding History

Meritage Portfolio Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-161,590
Closed -$9.51M – 205
2019
Q4 		$9.51M Sell
161,590
-1,066
-0.7% -$57.9K 0.84% 27
2019
Q3 		$8.31M Buy
162,656
+6,393
+4% +$304K 0.79% 29
2019
Q2 		$6.61M Buy
156,263
+2,640
+2% +$115K 0.67% 39
2019
Q1 		$7.59M Sell
153,623
-515
-0.3% -$23.3K 0.77% 33
2018
Q4 		$6.67M Sell
154,138
-6,334
-4% -$316K 0.76% 30
2018
Q3 		$9.11M Sell
160,472
-1,180
-0.7% -$62.1K 0.83% 21
2018
Q2 		$8.16M Sell
161,652
-1,260
-0.8% -$65.7K 0.79% 22
2018
Q1 		$8.12M Buy
162,912
+4,162
+3% +$196K 0.78% 24
2017
Q4 		$6.53M Sell
158,750
-2,857
-2% -$100K 0.63% 53
2017
Q3 		$4.8M Buy
161,607
+1,147
+0.7% +$35K 0.47% 99
2017
Q2 		$5.32M Buy
+160,460
New +$5.04M 0.55% 79

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Meritage Portfolio Management's GMED Position: Q1 2020 in Review

Meritage Portfolio Management sold out of Globus Medical (GMED) in Q1 2020, closing a stake of 161,590 shares — an estimated $9.51M sold.

Meritage Portfolio Management first reported a position in GMED in Q2 2017 and held it in 11 quarters. The position peaked at $9.51M in Q4 2019. 273 funds tracked by Wall St. Rank hold GMED as of Q1 2020.

  • Meritage Portfolio Management reported no remaining Globus Medical position as of Q1 2020 after selling out during the quarter.
  • Meritage Portfolio Management sold 161,590 Globus Medical shares in Q1 2020, an estimated $9.51M.
  • Meritage Portfolio Management first reported a position in Globus Medical in Q2 2017 and held it in 11 quarters.
  • Meritage Portfolio Management's Globus Medical position peaked at $9.51M in Q4 2019.
  • 273 funds tracked by Wall St. Rank held Globus Medical as of Q1 2020.

Based on Meritage Portfolio Management's 13F filing for Q1 2020, filed 27 Apr 2020.